Insiders / Afeyan Noubar

Afeyan Noubar

CIK 1222012personinsiderfund

Companies

3

First seen

Jan 15, 2026

Last activity

May 22, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Generate Biomedicines, Inc. · GENB	Director	37,656,659	15,264,724	38	—
Moderna, Inc. · MRNA	Director	3,924	13,187	4	—
Foghorn Therapeutics Inc. · FHTX	Director	—	—	0	—

All securities held

4 positions · latest reported per filing

Company	Security	Shares	As of
Generate Biomedicines, Inc.	Common Stock	37,656,659	Mar 2, 2026
Generate Biomedicines, Inc.	Stock Option (Right to Buy)Derivative	29,561	Feb 26, 2026
Moderna, Inc.	Common Stock	3,924	May 21, 2026
Moderna, Inc.	Stock Option (Right to Buy)Derivative	12,908	May 21, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Mar 2, 2026	Buy	GENB Generate Biomedicines, Inc. Common Stock	$25.00M	+1.6M	1,562,500 1.22% of shares	high
Mar 2, 2026	Buy	GENB Generate Biomedicines, Inc. Common Stock	$25.00M	+1.6M +56.25%	4,340,252 3.38% of shares	high
Mar 2, 2026	Buy	GENB Generate Biomedicines, Inc. Common Stock	$25.00M	+1.6M +11.40%	15,264,724 11.89% of shares	high
Mar 2, 2026	Buy	GENB Generate Biomedicines, Inc. Common Stock	$25.00M	+1.6M	1,562,500 1.22% of shares	high
Mar 2, 2026	Buy	GENB Generate Biomedicines, Inc. Common Stock	$25.00M	+1.6M +56.25%	4,340,252 3.38% of shares	high
Mar 2, 2026	Buy	GENB Generate Biomedicines, Inc. Common Stock	$25.00M	+1.6M +11.40%	15,264,724 11.89% of shares	high
May 21, 2026	Sell	MRNA Moderna, Inc. Common Stock	$433.9K	-9K -70.24%	3,924 <0.01% of shares	medium
May 21, 2026	Exercise	MRNA Moderna, Inc. Common Stock	$177.4K	+9K +236.06%	13,187 <0.01% of shares	low
May 21, 2026	Exercise	MRNA Moderna, Inc. Stock Option (Right to Buy)	—	-9K -100.00%	0 0.00% of shares	low
May 6, 2026	Grant	MRNA Moderna, Inc. Stock Option (Right to Buy)	—	+13K	12,908 <0.01% of shares	low